Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8610438rdf:typepubmed:Citationlld:pubmed
pubmed-article:8610438lifeskim:mentionsumls-concept:C0042776lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0042216lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0449297lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0205224lld:lifeskim
pubmed-article:8610438lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:8610438pubmed:issue2lld:pubmed
pubmed-article:8610438pubmed:dateCreated1996-5-30lld:pubmed
pubmed-article:8610438pubmed:abstractTextRecent reports have highlighted a potential antiviral activity for nitric oxide (NO). The purpose of this study was to investigate the production of NO in mice during vaccinia virus (VV) or herpes simplex virus type 1 infection, and to assess the role of NO in clearance of VV. Reactive nitrogen intermediates (RNI; NO and its stable oxidation products, nitrite and nitrate) were significantly elevated in the plasma of mice infected with these viruses. Furthermore, spleen cells from virus-infected mice produced elevated RNI levels following stimulation in vitro with LPS. NO production during VV infection was critically dependent on the cytokines tumor necrosis factor and interferon-gamma, and on the presence of both CD4+ and CD8+ T lymphocytes. Treatment of VV-infected mice with the nitric oxide synthase inhibitor N(G)-methyl-L-arginine did not alter the course of infection, suggesting that NO may not be essential for the clearance of this virus.lld:pubmed
pubmed-article:8610438pubmed:languageenglld:pubmed
pubmed-article:8610438pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8610438pubmed:citationSubsetIMlld:pubmed
pubmed-article:8610438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8610438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8610438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8610438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8610438pubmed:statusMEDLINElld:pubmed
pubmed-article:8610438pubmed:monthMarlld:pubmed
pubmed-article:8610438pubmed:issn0042-6822lld:pubmed
pubmed-article:8610438pubmed:authorpubmed-author:RamshawI AIAlld:pubmed
pubmed-article:8610438pubmed:authorpubmed-author:CowdenW BWBlld:pubmed
pubmed-article:8610438pubmed:authorpubmed-author:RockettK AKAlld:pubmed
pubmed-article:8610438pubmed:authorpubmed-author:RubyJJlld:pubmed
pubmed-article:8610438pubmed:authorpubmed-author:RolphM SMSlld:pubmed
pubmed-article:8610438pubmed:issnTypePrintlld:pubmed
pubmed-article:8610438pubmed:day15lld:pubmed
pubmed-article:8610438pubmed:volume217lld:pubmed
pubmed-article:8610438pubmed:ownerNLMlld:pubmed
pubmed-article:8610438pubmed:authorsCompleteYlld:pubmed
pubmed-article:8610438pubmed:pagination470-7lld:pubmed
pubmed-article:8610438pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:meshHeadingpubmed-meshheading:8610438-...lld:pubmed
pubmed-article:8610438pubmed:year1996lld:pubmed
pubmed-article:8610438pubmed:articleTitleNitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.lld:pubmed
pubmed-article:8610438pubmed:affiliationDivision of Cell Biology, John Curtin School of Medical Research, Canberra, Australia.lld:pubmed
pubmed-article:8610438pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8610438pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8610438lld:pubmed